21 November 2017
News and Views
Links and Services
This month's Annals of Internal Medicine evaluates the re-treatment of chronic Hepatitis C virus genotype 1 infection after relapse.
The interferon–free regimen of sofosbuvir and ribavirin for 24 weeks was recently approved to tre
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors